The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Not sure where all the shares from Richard Griffiths went but this is the current list of the top ten share holders in Reneuron.
Obotrita 7.83% ,Octopas 5.86% ,Rosetta cap 5.63 %, Arix cap 5.25% , The Invus 3.73% , Evans Sir Cristopher 2.45%, Evans Mark, 1.56% , Aberdeen Assets 1.03% Spreadex Ltd 0.73%
Richard Griffiths had 11.48% sold out on the 8th Dec now not listed as a share holder.
Hi Phill I have 60K shares and in the same sinking boat as you. Been here since 2017 and was taken in by all the hype by the BOD and others on this board . Have learnt a expensive lesson over the 5 years but still hope for Reneuron to come good over the next 12 months but as I have said before the CFO does not have much of a hand to play to get a good deal over the next 12 months for the company or its long suffering shareholders, but we can all hope she can pull it off.
I was under the impression that the BOD were prohibited from issuing more shares , I think after this presentation maybe they will ask the shareholders again if they can issue more shares to fund the purchase. IE more dilution.
With the market cap at £8miil and £ 12.5 mill in the bank why would anyone do a deal when the could buy the company and take the cash and all patents and show a profit. I feel for the current CFO she has not many cards to play to get a good deal either for the company or the long suffering share holders.
I would like to thank BD for all his efforts today a job well done, 38% was a great result even after the BOD telephone calls the get support given that the shareholder list not available to BD. Be interesting to know is this was raised at the meeting.